Regenerative Medicine Market in US Growth by 2020
©
Market outlook of the regenerative medicine market in the US
Regenerative medicine deals with the process of using therapeutically-induced or laboratory grown human tissue to treat diseased or injured human cells, tissues, or organs. It is an emerging field of treatment that helps in producing new cells to substitute malfunctioning or injured cells as a vehicle to treat disease and injury. The regenerative medicine market can be characterized into three major modalities, namely tissue engineering, biomaterials/biomolecules, and stem cell therapy.
Read more at: http://www.researchbeam.com/regenerative-medicine-in-the-us-market
Researchbeam market research analysts expect the regenerative medicine market in the US to grow at a fast pace, posting a remarkable CAGR of more than 33% during the forecast period because of the growing demand for tissue-engineered and stem cell products for the treatment of various diseases. The potential of these medicines in regenerating diseased organs is one of the major factors that drives the market in the US. The stem cells application and advancements in nanotechnology will further drive the progress in this market.
Segmentation by product and analysis of - cell therapy and scaffold
Cell therapy helps in treating the diseases or to improving the functioning of the existing cells, by administrating of cells into the body. This therapy addresses medical conditions related to the bone, cartilage, heart, skin, digestive system, reproductive system, eye, blood, spine, brain, and the nervous system. In 2015, cell therapy segment accounted for approximately 80% of the market share.
The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -
Cell therapy
Scaffold
Segmentation by application and analysis of - dermatology, musculoskeletal, ocular, and cardiovascular
The year 2015 saw the precedence of the dermatology segment, accounting for a market share of more than 51%. Dermatology includes the treatment of burns and chronic wounds that requires a quick response, and skin grafting is essential in many cases. Factors such as the increase in obesity and diabetes, growing elderly population, and an increase in life expectancy are some of the causes contributing to the growth of the dermatology market.
The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -
Dermatology
Musculoskeletal
Ocular
Cardiovascular
Competitive landscape and key vendors - AkzoNobel, Jotun, PPG
Regenerative medicine market in the US is highly competitive and fragmented because of the presence of several established vendors and this competitive environment is expected to intensify with advances in R&D and technological innovations. International players are likely to acquire regional or local players to enhance their products and expand their market share during the forecast period.
The top vendors in the market are -
Acelity
Mesoblast
Organogenesis
Reprocell
Stryker
Other prominent vendors include
Aastrom Biosciences
Acologix
AlloCure
Allosource
Alphatec Spine
Altrika
Amorcyte
Argos Therapeutics
Athersys
Avita Medical
Axogen
Bacterin International
Baxter
Bellicum Pharmaceuticals
BioCardia
BioLife Solutions
BioRestorative Therapies
BioTissue Technologies
Bluebird Bio,
BrainStorm Cell Therapeutics,
Calimmune
Capricor
Celyad (Cardio3 BioSciences)
Cell Medica
Cesca
CryoLife
Cynata Therapeutics
Cytori
Cytori Therapeutics
Dendreon
DiscGenics
Fate Therapeutics
Fibrocell
Fibrocell Science
Forticell Bioscience
Fortress Biotech
Gamida Cell
Geron
Harvard Apparatus Regenerative Technology
Healthpoint
Histogen
Histogenics
Humacyte
Immunocellular Therapeutics P
Integra Life Sciences
Intercytex
InVivo Therapeutics
iSTO Technologies
Juventas Therapeutics
Kensey Nash
Kiadis Pharma
Kinetic Concept
Living Cell Technologies
MaxCyte
Medtronics
Mesoblast
MiMedix Group
Nanofiber Solutions CTO
Nanotope, Neuralstem
Newlink Genetics
Northwest Biotherapeutics
NovaRx
Ocata Therapeutics
Opexa
Therapeutics
Organovo Holdings
Orteq
Orthofix
Osiris Therapeutics
Osteotech, Pfizer
Pluristem Therapeutics
Prima BioMed
Q Therapeutics
RhinoCyte
RTI Surgical
SanBio
Sangamo
Shire Regenerative Medicine
StemCells
Stratatech
TEI Biosciences
Tengion
Thermo Fischer Scientific
TiGenix
Tissue Genesis
TissueGene
VentriNova
Vericel
ViaCyte
Vistagen
and Zimmer.
Key questions answered in the report include
What will the market size and the growth rate be in 2020?
What are the key factors driving the regenerative medicine market in the US?
What are the key market trends impacting the growth of the regenerative medicine market in the US?
What are the challenges to market growth?
Who are the key vendors in the regenerative medicine market in the US?
What are the market opportunities and threats faced by the vendors in the regenerative medicine market in the US?
What are the key outcomes of the five forces analysis of the regenerative medicine market in the US?
Researchbeam also offers customization on reports based on specific client requirement.
Related reports
Global Stem Cell Banking Market 2015-2019
Global Human Insulin Market 2015-2019
Global Cell Counting Market 2015-2019
Global Tissue Diagnostics Market 2014-2018
Global Orthopedic Soft Tissue Repair Devices Market 2014-2018
Request report sample @ http://www.researchbeam.com/regenerative-medicine-in-the-us-market/enquire-about-report
Table of Contents
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Gene therapy: An emerging field in regenerative medicine
PART 06: Pipeline portfolio
PART 07: Regulatory scenario
FDA process
About Us:
With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency. With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.
Contact Us:
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
U.S. & Canada Toll Free: + 1-800-910-6452
International: + 1-503-894-6022
UK: + 44-845-528-1300
India: +91 20 66346070
Fax : +1 (855) 550-5975
Email: help@researchbeam.com
Web: http://www.researchbeam.com/
Regenerative medicine deals with the process of using therapeutically-induced or laboratory grown human tissue to treat diseased or injured human cells, tissues, or organs. It is an emerging field of treatment that helps in producing new cells to substitute malfunctioning or injured cells as a vehicle to treat disease and injury. The regenerative medicine market can be characterized into three major modalities, namely tissue engineering, biomaterials/biomolecules, and stem cell therapy.
Read more at: http://www.researchbeam.com/regenerative-medicine-in-the-us-market
Researchbeam market research analysts expect the regenerative medicine market in the US to grow at a fast pace, posting a remarkable CAGR of more than 33% during the forecast period because of the growing demand for tissue-engineered and stem cell products for the treatment of various diseases. The potential of these medicines in regenerating diseased organs is one of the major factors that drives the market in the US. The stem cells application and advancements in nanotechnology will further drive the progress in this market.
Segmentation by product and analysis of - cell therapy and scaffold
Cell therapy helps in treating the diseases or to improving the functioning of the existing cells, by administrating of cells into the body. This therapy addresses medical conditions related to the bone, cartilage, heart, skin, digestive system, reproductive system, eye, blood, spine, brain, and the nervous system. In 2015, cell therapy segment accounted for approximately 80% of the market share.
The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -
Cell therapy
Scaffold
Segmentation by application and analysis of - dermatology, musculoskeletal, ocular, and cardiovascular
The year 2015 saw the precedence of the dermatology segment, accounting for a market share of more than 51%. Dermatology includes the treatment of burns and chronic wounds that requires a quick response, and skin grafting is essential in many cases. Factors such as the increase in obesity and diabetes, growing elderly population, and an increase in life expectancy are some of the causes contributing to the growth of the dermatology market.
The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -
Dermatology
Musculoskeletal
Ocular
Cardiovascular
Competitive landscape and key vendors - AkzoNobel, Jotun, PPG
Regenerative medicine market in the US is highly competitive and fragmented because of the presence of several established vendors and this competitive environment is expected to intensify with advances in R&D and technological innovations. International players are likely to acquire regional or local players to enhance their products and expand their market share during the forecast period.
The top vendors in the market are -
Acelity
Mesoblast
Organogenesis
Reprocell
Stryker
Other prominent vendors include
Aastrom Biosciences
Acologix
AlloCure
Allosource
Alphatec Spine
Altrika
Amorcyte
Argos Therapeutics
Athersys
Avita Medical
Axogen
Bacterin International
Baxter
Bellicum Pharmaceuticals
BioCardia
BioLife Solutions
BioRestorative Therapies
BioTissue Technologies
Bluebird Bio,
BrainStorm Cell Therapeutics,
Calimmune
Capricor
Celyad (Cardio3 BioSciences)
Cell Medica
Cesca
CryoLife
Cynata Therapeutics
Cytori
Cytori Therapeutics
Dendreon
DiscGenics
Fate Therapeutics
Fibrocell
Fibrocell Science
Forticell Bioscience
Fortress Biotech
Gamida Cell
Geron
Harvard Apparatus Regenerative Technology
Healthpoint
Histogen
Histogenics
Humacyte
Immunocellular Therapeutics P
Integra Life Sciences
Intercytex
InVivo Therapeutics
iSTO Technologies
Juventas Therapeutics
Kensey Nash
Kiadis Pharma
Kinetic Concept
Living Cell Technologies
MaxCyte
Medtronics
Mesoblast
MiMedix Group
Nanofiber Solutions CTO
Nanotope, Neuralstem
Newlink Genetics
Northwest Biotherapeutics
NovaRx
Ocata Therapeutics
Opexa
Therapeutics
Organovo Holdings
Orteq
Orthofix
Osiris Therapeutics
Osteotech, Pfizer
Pluristem Therapeutics
Prima BioMed
Q Therapeutics
RhinoCyte
RTI Surgical
SanBio
Sangamo
Shire Regenerative Medicine
StemCells
Stratatech
TEI Biosciences
Tengion
Thermo Fischer Scientific
TiGenix
Tissue Genesis
TissueGene
VentriNova
Vericel
ViaCyte
Vistagen
and Zimmer.
Key questions answered in the report include
What will the market size and the growth rate be in 2020?
What are the key factors driving the regenerative medicine market in the US?
What are the key market trends impacting the growth of the regenerative medicine market in the US?
What are the challenges to market growth?
Who are the key vendors in the regenerative medicine market in the US?
What are the market opportunities and threats faced by the vendors in the regenerative medicine market in the US?
What are the key outcomes of the five forces analysis of the regenerative medicine market in the US?
Researchbeam also offers customization on reports based on specific client requirement.
Related reports
Global Stem Cell Banking Market 2015-2019
Global Human Insulin Market 2015-2019
Global Cell Counting Market 2015-2019
Global Tissue Diagnostics Market 2014-2018
Global Orthopedic Soft Tissue Repair Devices Market 2014-2018
Request report sample @ http://www.researchbeam.com/regenerative-medicine-in-the-us-market/enquire-about-report
Table of Contents
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Gene therapy: An emerging field in regenerative medicine
PART 06: Pipeline portfolio
PART 07: Regulatory scenario
FDA process
About Us:
With the arsenal of different search reports, Research Beam helps you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency. With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.
Contact Us:
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
U.S. & Canada Toll Free: + 1-800-910-6452
International: + 1-503-894-6022
UK: + 44-845-528-1300
India: +91 20 66346070
Fax : +1 (855) 550-5975
Email: help@researchbeam.com
Web: http://www.researchbeam.com/